Results

RDF/XMLNTriplesTurtleShow queryShare ▶
SubjectPredicateObject
http://purl.uniprot.org/citations/33908348http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/33908348http://www.w3.org/2000/01/rdf-schema#comment"

Background

Hypoxia and consequent production of vascular endothelial growth factor A (VEGFA) promote blood vessel leakiness and edema in ocular diseases. Anti-VEGFA therapeutics may aggravate hypoxia; therefore, therapy development is needed.

Methods

Oxygen-induced retinopathy was used as a model to test the role of nitric oxide (NO) in pathological neovascularization and vessel permeability. Suppression of NO formation was achieved chemically using L-NMMA, or genetically, in endothelial NO synthase serine to alanine (S1176A) mutant mice.

Results

Suppression of NO formation resulted in reduced retinal neoangiogenesis. Remaining vascular tufts exhibited reduced vascular leakage through stabilized endothelial adherens junctions, manifested as reduced phosphorylation of vascular endothelial (VE)-cadherin Y685 in a c-Src-dependent manner. Treatment with a single dose of L-NMMA in established retinopathy restored the vascular barrier and prevented leakage.

Conclusions

We conclude that NO destabilizes adheren junctions, resulting in vascular hyperpermeability, by converging with the VEGFA/VEGFR2/c-Src/VE-cadherin pathway.

Funding

This study was supported by the Swedish Cancer foundation (19 0119 Pj ), the Swedish Research Council (2020-01349), the Knut and Alice Wallenberg foundation (KAW 2020.0057) and a Fondation Leducq Transatlantic Network of Excellence Grant in Neurovascular Disease (17 CVD 03). KAW also supported LCW with a Wallenberg Scholar grant (2015.0275). WCS was supported by Grants R35 HL139945, P01 HL1070205, AHA MERIT Award. DV was supported by grants from the Deutsche Forschungsgemeinschaft, SFB1450, B03, and CRU342, P2."xsd:string
http://purl.uniprot.org/citations/33908348http://purl.org/dc/terms/identifier"doi:10.7554/elife.64944"xsd:string
http://purl.uniprot.org/citations/33908348http://purl.uniprot.org/core/author"Sessa W.C."xsd:string
http://purl.uniprot.org/citations/33908348http://purl.uniprot.org/core/author"Vestweber D."xsd:string
http://purl.uniprot.org/citations/33908348http://purl.uniprot.org/core/author"Claesson-Welsh L."xsd:string
http://purl.uniprot.org/citations/33908348http://purl.uniprot.org/core/author"Hedlund M."xsd:string
http://purl.uniprot.org/citations/33908348http://purl.uniprot.org/core/author"Smith R.O."xsd:string
http://purl.uniprot.org/citations/33908348http://purl.uniprot.org/core/author"Ninchoji T."xsd:string
http://purl.uniprot.org/citations/33908348http://purl.uniprot.org/core/author"Love D.T."xsd:string
http://purl.uniprot.org/citations/33908348http://purl.uniprot.org/core/date"2021"xsd:gYear
http://purl.uniprot.org/citations/33908348http://purl.uniprot.org/core/name"Elife"xsd:string
http://purl.uniprot.org/citations/33908348http://purl.uniprot.org/core/pages"e64944"xsd:string
http://purl.uniprot.org/citations/33908348http://purl.uniprot.org/core/title"eNOS-induced vascular barrier disruption in retinopathy by c-Src activation and tyrosine phosphorylation of VE-cadherin."xsd:string
http://purl.uniprot.org/citations/33908348http://purl.uniprot.org/core/volume"10"xsd:string
http://purl.uniprot.org/citations/33908348http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/33908348
http://purl.uniprot.org/citations/33908348http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/33908348
http://purl.uniprot.org/uniprot/#_E9Q9X4-mappedCitation-33908348http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/33908348
http://purl.uniprot.org/uniprot/#_A0A1L1STA1-mappedCitation-33908348http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/33908348
http://purl.uniprot.org/uniprot/#_A0A1B0GQW9-mappedCitation-33908348http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/33908348
http://purl.uniprot.org/uniprot/#_A0A1L1SQQ5-mappedCitation-33908348http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/33908348
http://purl.uniprot.org/uniprot/#_A0A1L1SR46-mappedCitation-33908348http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/33908348
http://purl.uniprot.org/uniprot/#_P41241-mappedCitation-33908348http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/33908348
http://purl.uniprot.org/uniprot/#_Q3UVH2-mappedCitation-33908348http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/33908348
http://purl.uniprot.org/uniprot/#_P55284-mappedCitation-33908348http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/33908348
▶